JR_Harris

PhD in Biology from Johns Hopkins University with an interest in #Biotechnology #Genomics and #Healthcare. #Investor and #VentureCaptial partner. Seeking truth.

[JR_Harris @JRHarrisTech]

@ciscojmd The Stratys is a disappointing product since there is no innovation nor improvements in performance relative to the Saphyr. Just 12 individual samples on a carousel for Stratys versus 3 samples on one chip for Saphyr. Irrelevant since demand for OGM has been abysmal.

[JR_Harris @JRHarrisTech]

@Captain_Miguel1 @ahoischen @GeneticNijmegen @radboudumc @nevelingk @JannekeWeiss @LisenkaVissers Yes, the Revio systems from PacBio are truly revolutionary and "game changers" in the field of multi-omics clinical research. I'd love to hear Alex's feedback on his two Revio systems that are being used to do long-read WGS. With the Revio you get DNA, RNA and methylation data!

[PacBio @PacBio]

Thank YOU for making #ASHG23 an incredible experience! From attending our packed workshop and CoLabs to bringing your positive energy to the #PacBio party, here's to a bright future filled with more groundbreaking #genomics discoveries.🌟 #ASHG2023

[JR_Harris @JRHarrisTech]

@professor_gene @bionano Unfortunately, OGM requires cell culture for use in prenatal diagnosis. The current standard of care, which is chromosomal microarray analysis (CMA) doesn't require cell culture. Cell culturing adds significant time and can also introduce artifacts in the results.

[PacBio @PacBio]

🎉 Celebrating 1 Year of Revio! 🧬

We are blown away by the exceptional high throughput and outstanding accuracy of the #Revio data achieved by our #PacBio customers. Here's to many more years of game-changing discoveries!

#ASHG23 #ASHG2023 #RevioAnniversary

[Shay Boloor @StockSavvyShay]

Genomic stocks are still in the early innings but looking at their current EV -- they've have all been CRUSHED the past two years that these names are now criminally undervalued🤯

$CRSP, $DNA, $NTLA, $BEAM, $TWST, $VERV, $PRME, $EDIT, $CRBU, $NVTA

[JR_Harris @JRHarrisTech]

@ciscojmd @EHolmlin @adwivedi17 @Hannah_Mamuszka @LinneyYvonne @Aleks_Rajkovic I'm 100% convinced Erik Holmlin has been involved in nefarious activities as the CEO of a publicly traded company and he should be immediately investigated by the @SECGov. There are too many red flags surrounding him to ignore.

[PacBio @PacBio]

Incredible experience at the #PacBio party tonight! The positive energy and the coming together to celebrate the #ASHG23 community are always one of our favorite parts.

#ASHG2023

[Richard Shippy @RichShippy]

The use of long-read sequencing (LRS) with multiomics techniques, such as DNA methylation status, can robustly screen and identify often-missed genetic determinants of rare diseases ⁦@ChildrensMercy⁩ #genomics #multiomics #LRS #WGS https://t.co/9fC247WtZY

[PacBio @PacBio]

Just Announced: We are convening a global consortium of researchers from 15 leading genomics research institutions across eleven countries to study the value HiFi-based human genome sequencing may have in clinical research applications and to further our understanding of genetic diseases. https://t.co/lfvTBH9xJv

#PacBio #ASHG23 #ASHG2023

[Richard Shippy @RichShippy]

Oxford Nanopore Technologies and ⁦@saphetor⁩ announce a new partnership to provide integrated end-to-end solutions (from sample to report) for the comprehensive analysis of whole genome ⁦@nanopore⁩ sequencing data in clinical applications. https://t.co/hNeI585u5M

[PacBio @PacBio]

Join us at #ASHG23 next week during our workshop and CoLab 1 to learn how HiFi sequencing is helping to answer difficult #RareDisease questions. https://t.co/a8oYlz2hEN

#PacBio #ASHG2023

[JR_Harris @JRHarrisTech]

@IBHenryJ @AggressiveRisk @BonusLevelFund I've been trying my best to warn retail investors and Dayo since the SP of $BNGO was at $1.54 pre-R/S ($15.40 post-R/S) that Bionano was headed towards Nasdaq noncompliance, the R/S and eventually bankruptcy. Down -92% since my initial warning. Bankruptcy will happen in Q2-2024.

[JR_Harris @JRHarrisTech]

@BonusLevelFund I'm very disappointed to see that you've been promoting $BNGO through 2023 and asked us to join you by investing $5,000 on April 14th, when the SP was $11.40 (post R/S), but you haven't held any shares since last year. Those that listened to you on April 14th are now down -84%!👇

[JR_Harris @JRHarrisTech]

@ElonsFan1 @BonusLevelFund Dayo should not have lied to his followers by pretending he invested in $BNGO in 2023. He claims his videos are for "entertainment only" yet he asked his followers to invest $5,000 into BNGO on April 14, and those that did are down -88% relative to today, which is a $4,406 loss.

[Oxford Nanopore @nanopore]

Scale up your sequencing.

Nanopore technology’s ability to process multiple samples simultaneously streamlines large cohort studies. In this guide learn how to detect structural variants across thousands of samples with ease and efficiency.

Read here: https://t.co/GiZbN7Nr0l

[JR_Harris @JRHarrisTech]

@ciscojmd @EHolmlin @bionano @Hannah_Mamuszka @LinneyYvonne @adwivedi17 Erik lied when he said the reverse split wasn't a sign of distress and he continues to mislead investors with his hyperbolic language. I don't see any way for $BNGO to avoid bankruptcy within the next 6 months. It is sad since shareholders will walk away with nothing.

[JR_Harris @JRHarrisTech]

@BonusLevelFund Dayo, you owe your followers an apology for lying to them on April 14, 2023, saying you bought shares and for misrepresenting your position. You haven't held a position in $BNGO since 2022. I wish you would act more responsibly and not mislead people just to gain subscribers.🙏

[JR_Harris @JRHarrisTech]

@BonusLevelFund I'm very disappointed to see that you've been promoting $BNGO through 2023 and asked us to join you by investing $5,000 on April 14th, when the SP was $11.40 (post R/S), but you haven't held any shares since last year. Those that listened to you on April 14th are now down -84%!👇